New research suggests less intensive treatment can benefit cancer patients in ovarian, esophageal, and Hodgkin lymphoma cases, improving quality of life without affecting outcomes.

New research finds that cancer patients often benefit from less intensive treatment, particularly in cases of ovarian, esophageal, and Hodgkin lymphoma. Scaling back treatment can improve patients' quality of life without affecting outcomes. Thirty years ago, cancer research focused on administering more treatment, but recent studies suggest that optimizing cancer care may require reconsidering past treatment methods.